Ryan Stewart, DO
Ryan Stewart, DO
Board-certified and fellowship-trained urogynecologist
Green Bay, Wisconsin
✓ Medically reviewed November 6, 2026
No financial ties to any device or drug maker

Medications for overactive bladder and urge incontinence

Medications are a main treatment for overactive bladder (OAB) and urge incontinence. They don’t treat stress urinary incontinence, the leaking that happens when you cough, sneeze, or exercise. There are no FDA-approved medications for stress incontinence.

What these medications do

I may offer medication if you have overactive bladder symptoms: sudden urges to urinate, trouble holding it once the urge hits, going often, or leaking on the way to the bathroom. OAB medications calm the bladder muscle so it squeezes less often on its own and holds more urine before the urge starts.

They help, but the effect is moderate. In large reviews, about half of women taking an anticholinergic reported their symptoms were under control. Few women become completely dry on medication alone.

Types of medications

Anticholinergics (also called antimuscarinics)

These drugs block the nerve signals that make the bladder muscle contract when it shouldn’t. Six are FDA-approved for urge incontinence, and they work about equally well. The main differences between them are side effects.

  • Oxybutynin (Ditropan XL™, Oxytrol™)
  • Tolterodine (Detrol™)
  • Darifenacin (Enablex™)
  • Solifenacin (Vesicare™)
  • Trospium (Sanctura™)
  • Fesoterodine (Toviaz™)

Extended-release versions, taken once a day, cause less dry mouth than the immediate-release forms. Anticholinergics are not safe for people with untreated narrow-angle glaucoma, and they can make it harder to empty your bladder.

Beta-3 agonists

This newer class relaxes the bladder muscle during filling so it can hold more urine. They work about as well as anticholinergics with much less dry mouth and constipation, and they don’t carry the same concerns about memory and thinking.

  • Mirabegron (Myrbetriq™)
  • Vibegron (Gemtesa™)

Mirabegron can raise blood pressure, so I check yours before and during treatment. It isn’t used in people whose high blood pressure is not under control. Beta-3 agonists can also change the levels of some heart medications, including digoxin and metoprolol, so tell me everything you take.

Combination therapy

If one medication helps but not enough, adding a drug from the other class is a guideline-supported option. In large trials, solifenacin plus mirabegron reduced leaks more than either drug alone. Side effects such as dry mouth and constipation were slightly more common, and so was trouble emptying the bladder.

Side effects

Anticholinergics commonly cause:

  • Dry mouth
  • Constipation
  • Blurry vision
  • Drowsiness

Beta-3 agonists can cause:

  • Higher blood pressure
  • Headache
  • Cold-like symptoms such as a stuffy nose or sore throat
  • Urinary tract infections

Side effects are the main reason women stop. Fewer than half are still taking an anticholinergic six months after starting it.

Anticholinergics and dementia risk

Long-term use of anticholinergic medications has been linked to a higher risk of dementia.

  • In pooled studies, the risk rose with longer use. It was higher after 3 months of use and higher still after a year.
  • These studies show an association. They can’t prove the medication causes dementia, partly because bladder symptoms and dementia share risk factors.
  • Oxybutynin, especially the immediate-release form, has the most consistent evidence of short-term effects on memory and thinking. I avoid it for long-term use.
  • Trospium, darifenacin, and fesoterodine cross into the brain less, and studies have not shown cognitive decline with them. If an anticholinergic is the right choice, I use one of these.
  • The American Urogynecologic Society recommends avoiding anticholinergics for OAB where possible in women over 70.
  • Many other common medications have anticholinergic effects, including some antidepressants, allergy pills, and sleep aids. The total load matters, so I review your full medication list.

How I approach it

I start with a beta-3 agonist when medication makes sense, and I use anticholinergics with the lower-risk profiles at the lowest dose that works. I see you back within 4 to 8 weeks to check whether it’s helping. If it isn’t working or the side effects are too much, we stop it.

You don’t have to fail one or two pills before moving on. AUA guidelines don’t require you to try medication before Botox injections or neuromodulation, though some insurance plans do. In a large randomized trial, a single Botox injection reduced urge leaks as much as daily anticholinergic pills over six months, and more women became completely dry with Botox. Some women would rather skip daily pills altogether, and that’s a reasonable choice.

Lifestyle and behavioral changes and pelvic floor physical therapy stay part of the plan alongside any medication.

A bladder pill only makes sense if you’ll take it every day, so the side effects have to be ones you can live with.

Next steps

If you have overactive bladder or urge incontinence, schedule a consultation. Bring a list of every medication and supplement you take, and a few days of notes on how often you go and when you leak.

References

  • Lukacz ES, Santiago-Lastra Y, Albo ME, et al. Urinary Incontinence in Women: A Review. JAMA. 2017. doi:10.1001/jama.2017.12137
  • ACOG Committee on Practice Bulletins—Gynecology, American Urogynecologic Society, Kenton KS, et al. Urinary Incontinence in Women (ACOG Practice Bulletin No. 155). Obstetrics & Gynecology. 2015. doi:10.1097/AOG.0000000000001148
  • White N, Iglesia CB. Overactive Bladder. Obstetrics and Gynecology Clinics of North America. 2016. doi:10.1016/j.ogc.2015.10.002
  • Lightner DJ, Gomelsky A, Souter L, et al. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019. The Journal of Urology. 2019. doi:10.1097/JU.0000000000000309
  • Visco AG, Brubaker L, Richter HE, et al. Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence. New England Journal of Medicine. 2012. doi:10.1056/NEJMoa1208872
  • AUGS Guidelines Committee, Thomas TN, Walters MD. Clinical Consensus Statement: Association of Anticholinergic Medication Use and Cognition in Women With Overactive Bladder. Female Pelvic Medicine & Reconstructive Surgery. 2021. doi:10.1097/SPV.0000000000001008
  • Dengler KL, High RA, Moga DC, et al. Overactive Bladder and Cognitive Impairment: The American Urogynecologic Society and Pelvic Floor Disorders Research Foundation State-of-the-Science Conference Summary Report. Urogynecology. 2023. doi:10.1097/SPV.0000000000001272
  • Sanses TVD, Zillioux J, High RA, et al. Evidence-Informed, Interdisciplinary, Multidimensional Action Plan to Advance Overactive Bladder Research and Treatment Initiatives: Directives From State-of-the-Science Conference on Overactive Bladder and Cognitive Impairment. Urogynecology. 2023. doi:10.1097/SPV.0000000000001274

Copyright © 2016-2026 Ryan Stewart, DO. | Contact | Privacy Policy
The information provided is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional for personalized medical guidance.

Page last modified: Nov 6 2026.